VCAM-1/α4-integrin adhesion pathway: Therapeutic target for allergic inflammatory disorders

The Journal of Allergy and Clinical Immunology

Volumn 98, Issue 6 PART 2, 1996, Pages

  Foster, Carolyn A ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adhesion molecules; endothelial cells; inhibitors; review; VCAM 1; VLA 4

Indexed keywords

ANTIOXIDANT; ANTISENSE OLIGODEOXYNUCLEOTIDE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; MONOCLONAL ANTIBODY; PROTEINASE INHIBITOR; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGY; CELL ADHESION; CONFERENCE PAPER; GENE TRANSFER; HUMAN; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE MIGRATION INHIBITION; LYMPHOCYTE RECIRCULATION; PRIORITY JOURNAL; PROTEINASE INHIBITION;

ANIMALS; ANTIGENS, CD; AUTOIMMUNE DISEASES; CELL ADHESION MOLECULES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOTHERAPY; INTEGRIN ALPHA4; PROTEIN BINDING; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0030477285     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70075-1     Document Type: Article

References (86)

1. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates
2. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm
3. Leukocyte-endothelial adhesion molecules
4. Chemokines, leukocyte trafficking, and inflammation
5. CC chemokines in allergic inflammation
6. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site
7. VLA proteins in the integrin family: structures, functions, and their role on leukocytes
8. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1
9. Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells
10. NF-κB and IκBα: an inducible regulatory system in endothelial activation
11. NF-κB: a lesson in family values
12. Structure, regulation and function of NF-κB
13. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression
14. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of IκB-α phosphorylation
15. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells
16. Inhibition of NF-κB by pyrrolidine dithiocarbamate blocks endothelial cell activation
17. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
18. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-1 antigen-processing pathway
19. Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB
20. Dithiocarbamates as potent inhibitors of nuclear factor-κB activation in intact cells
21. Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts
22. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor
23. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis
24. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids
25. Inhibition of E-Selectin-, ICAM-1-, and VCAM-1-mediated cell adhesion by benzo[b]thiophene-, benzofuran-, indole-, and naphthalene-2-carboxamides: identification of PD 144795 as an antiinflammatory agent
26. Inhibitors of leukocyte-endothelial cell adhesion: a new generation of antiinflammatory therapeutics?
27. A CD18 monoclonal antibody increases the incidence and severity of subcutaneous abscess formation after high-dose Staphylococcus aureus injection in rabbits
28. Rheumatoid arthritis: pathophysiology and implications for therapy
29. Type I diabetes: a chronic autoimmune disease of human, mouse and rat
30. The T lymphocyte in experimental allergic encephalomyelitis
31. The pathogenesis of atherosclerosis - an update
32. Eosinophilic inflammation in asthma
33. Asthma and inflammation
34. Endothelial-leukocyte adhesion molecules in human disease
35. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerosis plaques
36. The expression of leukocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis
37. Expression of endothelial and leukocyte adhesion molecules intercellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma
38. Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients
39. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor or IFN-γ
40. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells
41. Interleukin-4 induces endothelial vascular cell adhesion molecule-1 (VCAM-1) by an NF-κb-independent mechanism
42. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNFα in cultured endothelial cells
43. Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo
44. Expression of adhesion molecules in early allergic patch test reactions
45. Vascular cell adhesion molecule-1: expression in normal and diseased skin and regulation in vivo by interferon gamma
46. Expression of murine VCAM-1 in vitro and in different models of inflammation in vivo correlation with immigration of monocytes
47. Tumor necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression
48. Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts
49. Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection
50. Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues
51. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma
52. Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis
53. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells
54. Expression of vascular cell adhesion molecule-1 in fibroblast-like synoviocytes after stimulation with tumor necrosis factor
55. Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110
56. Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis
57. Expanding roles for α4 integrin and its ligands in development
58. Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation
59. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice
60. Cell adhesion events mediated by α4 integrins are essential in placental and cardiac development
61. In vivo models of leukocyte adherence to endothelium
62. The pathophysiologic role of α4 integrins in vivo
63. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways
64. Role of the VLA-4 integrin in leukocyte recruitment and bronchial hyperresponsiveness in the guinea-pig
65. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue
66. Monoclonal antibodies to the integrin α-4 subunit inhibit the murine contact hypersensitivity response
67. Recruitment of lymphocytes during cutaneous delayed hypersensitivity in nonhuman primates is dependent on E-selectin and vascular cell adhesion molecule-1
68. Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo
69. Treatment with anti-vascular cell adhesion molecule 1 monoclonal antibody induces long-term murine cardiac allograft acceptance
70. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies
71. Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers
72. Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors
73. Administration of monoclonal antibodies against vascular cell adhesion molecule-1/very late antigen-4 abrogates predisposing autoimmune diabetes in NOD mice
74. The pathogenesis of adoptive murine autoimmune diabetes requires an interaction between α4-integrins and vascular cell adhesion molecule-1
75. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin
76. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma
77. 4-integrin receptors in vivo
78. A recombinant adenoviral vector expressing a soluble form of VCAM-1 inhibits VCAM-1/VLA-4 adhesion in transduced synoviocytes
79. The crystal structure of an N-terminal two-domain fragment of vascular cell adhesion molecule 1 (VCAM-1): a cyclic peptide based on the domain 1 C-D loop can inhibit VCAM-1 - α4 integrin interaction
80. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature
81. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary artheriopathy in rabbit cardiac allografts
82. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides
83. Pharmacological modulation of endothelial cell-associated adhesion molecule expression: implications for future treatment of dermatological diseases
84. The 3D-structure of a natural inhibitor of cell adhesion molecule expression
85. Novel inhibitor of endothelial cell-associated VCAM-1 expression
86. Inhibition of endothelial cell activation by adenovirus-mediated expression of IκBα an inhibitor of the transcription factor NF-κB